TrialLeukemia2013

Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial.

A K Burnett et al.PubMed ↗Publisher ↗

No numbers read from the abstract.